Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study
Conclusion: We were able to reveal several risk factors for lung disease progression in a large cohort of Dutch children with CF followed during six years. Particularly the potential risk of PPI use needs attention and further study. The precise mechanism underlying this risk is unclear.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: van Horck, M., van de Kant, K. D. G., Winkens, B., Wesseling, G., Gulmans, V., Hendriks, H., van der Grinten, C., Jobsis, Q., Dompeling, E. Tags: Cystic Fibrosis Source Type: research
More News: Allergy & Immunology | Aspergillosis | Children | Corticosteroid Therapy | Cystic Fibrosis | Diabetes | Endocrinology | Netherlands Health | Pancreas | Respiratory Medicine | Study